The global source for hematology education, practice and research

Disclaimer
Privacy statement

ISSN: 1478-1247

Home

Latest:

Breaking news.
7 February 2010	Australian treatment may go global A hemophilia treatment that is standard in Australia may become available world-wide following new trials.
7 February 2010	New source of stem cells from fat tissue? Hematopoietic stem cells derived from fat tissue may prove to be a viable alternative to cells taken from bone marrow.
7 February 2010	Fatty acids vital for leukemia cells Scientists have found that leukemia cells rely partly on fatty acids in order to survive.

Summaries of key papers selected by the editors.

The best reviews from the journals.

Dr William W Duke: Pioneer in platelet research.
Journal of the American Medical Association 2009; 301: 2267-2269.
Mesenchymal stem cells for clinical application
Vox Sanguinis 2010; 98: 93-107
Complications of massive transfusion.
Chest 2010; 137: 209-220.

Peer-reviewed articles summarizing hot topics, written specially for Bloodmed.com:

2nd London Lymphoma Forum
Robert Marcus and Chris McNamara, London Lymphoma Forum
Matriptase 2, a new and unexpected player in the iron field.
Dr Carole Beaumont, INSERM U773, Université Paris Diderot, site Bichat, 75018, Paris, France
Report from the XII congress of the International Society on Thrombosis and Haemostasis
Pamala Kanagasabapathy, Haemophilia Centre and Thrombosis Unit, Royal Free and University College Medical School

Current clinical guidelines.

Clinical practice guideline: red blood cell transfusion in adult trauma and critical care
Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, Hebert PC, Anderson GL, Bard MR, Bromberg W, Chiu WC, Cipolle MD, Clancy KD, Diebel L, Hoff WS, Hughes M, Munshi I, Nayduch D, Sandhu R, Yelon JA, for the American College of Critical Care Medicine of the Society of Critical Care Medicine and the Eastern Association for the Surgery of Trauma Practice Management Workgroup
Critical Care Medicine 2009; 37: 3124-3157
Venous thromboembolism: reducing the risk.
NICE
National Institute for Health and Clinical Excellence.Venous thromboembolism: reducing the risk. http://guidance.nice.org.uk/CG92
Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
ACCP
Chest. 2008 Jun; 133(6 Suppl): 110S-112S